RE:DesperationFact of the matter....whether someone holds a negative or positive outlook the opinions expressed here have ZERO effect on share price......most investors practice due diligence and don't place trades based on random comments made by strangers on the internet...... just like LP's stopped buying oils from labs and began extracting on their own......... it's time for Labs to stop buying buds from LP's and start growing their own to improve margins...it's natural progression which could have dramatic impacts on the road to profitability...I also became very pessimistic when dilution was happening due to debenture repayment which is why I sold all my shares last year...I'm back because the current valuation is one I'm comfortable with....if your views on the future are so grim why do you continue to hold a long position...why don't you cash in what's left and move on?....I'm here because I agree with reputable reports on global CBD market growth, the growth of cannabinoid pharmaceutical applications and the belief medipharm has the ability to grow with the market as a profitable organization...the products start with BUDS....they need to start producing it themselves...